Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 25;20(1):464.
doi: 10.1186/s12888-020-02824-5.

Idiographic analyses of motivation and related processes in participants with schizophrenia following a therapeutic intervention for negative symptoms

Bénédicte Thonon  1 , Evelyne Van Aubel  2 , Ginette Lafit  2   3 , Clara Della Libera  1 , Frank Larøi  4   5   6
Affiliations

Idiographic analyses of motivation and related processes in participants with schizophrenia following a therapeutic intervention for negative symptoms

Bénédicte Thonon et al. BMC Psychiatry. .

Abstract

Background: Motivational negative symptoms hinder quality of life and daily functioning of individuals with schizophrenia spectrum disorders. A recently developed intervention, Switch, has shown promising effects on negative symptoms and functional outcomes. Switch targets multiple cognitive, emotional and behavioural processes associated with motivation and goal directed behaviours. We aimed to investigate its effects on motivation and associated processes in a naturalistic setting, and to explore the dynamics between the processes.

Methods: We used a single case approach (n = 3), with a pre-post and follow-up assessment design, which also included ambulatory assessments (experience sampling method, ESM; and step count). We computed autoregressive lag 1 models to evaluate the effects of the intervention on daily motivation levels and related processes, descriptive pie-charts, and vector autoregressive modelling to reveal the dynamics of the processes over time.

Results: The intervention was beneficial for each participant according to traditional evaluations of motivational negative symptoms, apathy, daily functioning and quality of life. The effects on the ESM variables revealed distinct outcomes for each individual. The dynamics between the various processes differed between participants, and fluctuated within participants (when comparing baseline, intervention phase, and follow-up).

Conclusions: This study used an innovative approach to look at the effectiveness of an intervention. The intervention seems to lead to meaningful improvements in motivational negative symptoms and functional outcomes. The mechanisms of change need to be further investigated.

Trial registration number: ClinicalTrials.gov, NCT04325100 . Registered 27 March 27, 2020 -retrospectively registered.

Reporting: Guidelines from the Transparent Reporting of Evaluations with Non-randomized Designs (TREND) statement were followed.

Keywords: Apathy; Ecological momentary assessment; Intervention; Single case; Timeseries analyses, dynamics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Three-level model of motivation (reproduced with permission from [9])
Fig. 2
Fig. 2
Design of the study and assessment procedure. BNSS = Brief Negative Symptom Scale; LARS = Lille Apathy Rating Scale patient and informant; FROGS = Functional Remission of General Schizophrenia, S-QoL = Schizophrenia Quality of Life questionnaire
Fig. 3
Fig. 3
The motivation’s switch. Updated version of the decisional balance
Fig. 4
Fig. 4
Pie charts for nominal variables of participant 2i-1
Fig. 5
Fig. 5
Network models of participant 2i-1. Positive associations appear in green (continuous lines) and negative associations appear in red (dashed lines). The stronger the relationships, the thicker the edges. Only associations with p-values < .05 are plotted. For a colour version of this figure, see the digital version of the paper
Fig. 6
Fig. 6
Pie charts for nominal variables of participant 2i-2
Fig. 7
Fig. 7
Network models of participant 2i-1. Positive associations appear in green (continuous lines) and negative associations appear in red (dashed lines). The stronger the relationships, the thicker the edges. Only associations with p-values < .05 are plotted. For a colour version of this figure, see the digital version of the paper
Fig. 8
Fig. 8
Pie charts for nominal variables of participant 2i-4
Fig. 9
Fig. 9
Network models of participant 2i-4. Positive associations appear in green (continuous lines) and negative associations appear in red (dashed lines). The stronger the relationships, the thicker the edges. Only associations with p-values < .05 are plotted. For a colour version of this figure, see the digital version of the paper
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sauvé G, Brodeur MB, Shah JL, Lepage M. The prevalence of negative symptoms across the stages of the psychosis continuum. Harv Rev Psychiatry. 2019;27:15–32. doi: 10.1097/HRP.0000000000000184. - DOI - PubMed
    1. Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, et al. Deconstructing negative symptoms of schizophrenia: Avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res. 2013;47:783–790. doi: 10.1016/j.jpsychires.2013.01.015. - DOI - PMC - PubMed
    1. Horan WP, Kring AM, Gur RE, Reise SP, Blanchard JJ. Development and psychometric validation of the clinical assessment interview for negative symptoms (CAINS). Schizophr Res. 2011. - PMC - PubMed
    1. Beck AT, Himelstein R, Bredemeier K, Silverstein SM, Grant P. What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors. Psychol Med. 2018;48:2776–2785. doi: 10.1017/S0033291718000442. - DOI - PubMed
    1. Fervaha G, Foussias G, Agid O, Remington G. Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome. Schizophr Res. 2015;166:9–16. doi: 10.1016/j.schres.2015.04.040. - DOI - PubMed

Publication types

Associated data